Ozcan C, Strom JB, Newell JB, Mansour MC, Ruskin JN. Incidence and predictors of atrial brillation and its impact on long-term survival in patients with supraventricular arrhythmias. Europace. 2014;16(10):1508-1514. 9. Higgins J, Altman D, Sterne J, (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.cochrane-handbook.org. 2011. 10. Balshem H, Helfand M, Sch nemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401- 406. 11. Diekemper RL, Patel S, Mette SA, Ornelas J, Ouellette DR, Casey KR. Making the GRADE: CHEST updates its methodology. Chest. 2018;153(3):756-759. 12. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the signi cance and presentation of recommendations. J Clin Epidemiol. 2013;66(7): 719-725. 13. Lewis SZ, Diekemper R, Ornelas J, Casey KR. Methodologies for the development of CHEST guidelines and expert panel reports. Chest. 2014;146(1):182-192. 1188 Evidence-Based Medicine [ 1 5 4 # 5 C H E S T N O V E M B E R 2 0 1 8 ] 14. Jaeschke R; The GRADE Working Group. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337:327-330. 15. Lip GY, Fauchier L, Freedman SB, et al. Atrial brillation. Nat Rev Dis Primers. 2016;2:16016. 16. Lip GY, Brechin CM, Lane DA. The global burden of atrial brillation and stroke: a systematic review of the epidemiology of atrial brillation in regions outside North America and Europe. Chest. 2012;142(6):1489-1498. 17. Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial brillation. Lancet. 2016;388(10046):806-817. 18. Allan V, Honarbakhsh S, Casas JP, et al. Are cardiovascular risk factors also associated with the incidence of atrial brillation? 